Life Science News

Latest updates from the biotech and pharma world

BioPharma Dive 2025-12-16

FDA ‘proactively’ hands J&J a voucher; Pfizer issues 2026 forecasts

BioPharma Dive 2025-12-16

Enhertu combo cleared for use in frontline breast cancer

BioPharma Dive 2025-12-16

‘Zombie’ biotech buyer Xoma to acquire Generation Bio

BioPharma Dive 2025-12-15

Argenx falters in effort to expand immune drug’s use

BioPharma Dive 2025-12-15

Sanofi MS drug hits two setbacks

BioPharma Dive 2025-12-15

Kyverna to seek first clearance of a CAR-T therapy for autoimmune disease

BioPharma Dive 2025-12-15

How rare-disease teams can fine-tune COAs to bridge meaningful change and measurable progress

BioPharma Dive 2025-12-14

Sobi snaps up gout drug in $950M deal for startup Arthrosi

BioPharma Dive 2025-12-12

Arcus cancels work on Gilead-partnered cancer combo after trial setback

BioPharma Dive 2025-12-12

Praxis tees up another approval filing; Geron turns to layoffs

BioPharma Dive 2025-12-11

AC Immune posts positive data for Parkinson’s immunotherapy

BioPharma Dive 2025-12-11

Biotech venture firm Apple Tree goes bankrupt amid dispute with billionaire backer

BioPharma Dive 2025-12-11

Lilly’s three-pronged drug puts obesity field ‘on notice’

BioPharma Dive 2025-12-11

Crapo, Cassidy propose enhanced ACA subsidy alternative

BioPharma Dive 2025-12-11

Prolynx banks $70M for longer-lasting obesity drugs

BioPharma Dive 2025-12-10

FDA approves first drug in National Priority Voucher program

BioPharma Dive 2025-12-10

A former Roivant spinout bets on AI-designed drugs for immune conditions

BioPharma Dive 2025-12-09

Novartis notches another win for drug acquired in MorphoSys deal

BioPharma Dive 2025-12-09

Pfizer dips into China for another try at an obesity pill

BioPharma Dive 2025-12-09

FDA raises CAR-T approval standards; Novartis bets on an AI startup

4 / 7